Lessons from innovation in drug-device combination products
Drug-device combination products introduced a new dynamic on medical product development, regulatory approval, and corporate interaction that provide valuable lessons for the development of new generations of combination products. This paper examines the case studies of drug-eluting stents and trans...
Main Authors: | Couto, Daniela S. (Author), Perez-Breva, Luis (Contributor), Saraiva, Pedro M. (Contributor), Cooney, Charles L (Contributor) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Cooney, Charles L. (Contributor) |
Format: | Article |
Language: | English |
Published: |
Elsevier,
2017-04-13T19:43:12Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Regenerative Medicine: Learning from Past Examples
by: Couto, Daniela S., et al.
Published: (2012) -
In Silico Methods for Development of Generic Drug–Device Combination Orally Inhaled Drug Products
by: Ross L. Walenga, et al.
Published: (2019-06-01) -
DNA binding economies
by: Pérez-Breva, Luis
Published: (2008) -
Enabling Open Innovation: Lessons from Haier
by: Arie Y. Lewin, et al.
Published: (2017-01-01) -
Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials
by: Bibhuti B. Das, et al.
Published: (2021-04-01)